Purpose: Stereotactic body radiation therapy (SBRT) combining trans-arterial chemoembolization (TACE) with Lipiodol is expected to improve local control. This study is aimed to estimate the dose enhancement in Lipiodol's proximity and to evaluate the dose calculation accuracy of the Acuros XB (AXB) algorithm and anisotropic analytical algorithm (AAA) in the Eclipse treatment planning system (TPS) (ver. 11, Varian Medical Systems, Palo Alto, USA), compared with that of the Monte Carlo (MC) calculation (using BEAMnrc/DOSXYZnrc code) for a virtual phantom and a treatment plan for liver SBRT after TACE. Methods: The MC calculation accuracy was validated by comparing its results with the percent depth dose (PDD) and the off-axis ratio (OAR) measured using a water-equivalent phantom containing Lipiodol. The dose difference in Lipiodol's proximity and the inhomogeneity correction accuracies of the AAA, AXB algorithm, and MC calculation were evaluated by calculating the PDDs and OARs for the virtual phantom with Lipiodol and the lateral profile for the clinical plan data. Results: The measured data and the MC results agreed within 3%. The average dose in the Lipiodol uptake region was higher by 8.1% for the virtual phantom and 6.0% for the clinical case compared to that in regions without Lipiodol uptake. For the virtual phantom, compared with the MC calculation, the AAA and the AXB algorithm underestimated the doses immediately upstream of the Lipiodol region by 5.0% and 4.2%, in the Lipiodol region by 7.4% and 9.8%, and downstream of the Lipiodol region by 5.5% and 3.9% respectively. These discrepancy between the AXB and MC calculations were due to the incorrect assignment of Lipiodol material properties. Namely, the bone material was assigned automatically by the AXB algorithm as the materials for the AXB algorithm do not contain iodine, which is the main constituent of Lipiodol. Conclusions: The MC calculation indicated a larger and more accurate dose increase in Lipiodol compared with the TPS algorithms. The observed dose enhancement in the tumor area could be clinically significant.
INTRODUCTION
The objective of stereotactic body radiation therapy (SBRT) for liver cancer is to improve local control and minimize the dose to the intact normal tissue.
1,2 A high dose delivered using hypo-fractionation enhances tumor control. Accurate daily localization of the target volume is imperative owing to a large dose delivered in a short period of time. 3, 4 Lipiodol has been used as an embolic agent in trans-arterial chemoembolization (TACE) for tumor seeking as it can be visualized in diagnostic computerized tomography (CT) and cone beam CT (CBCT). 5 Several institutions have recently reported promising responses in patients with unrespectable hepatocellular carcinoma treated with TACE followed by radiation therapy (RT). 6, 7 TACE is considered a minimally invasive treatment of liver metastases. Combining TACE with a local ablative treatment is promising for treating unrespectable liver tumors. Furthermore, TACE combined with RT is promising for using Lipiodol for tumor localization without additional invasive procedures compared with a fiducial marker implantation. 8, 9 Dawson et al. proposed that tumors pre-treated by TACE with Lipiodol may be used for direct targeting with CBCT. 10 Recent studies suggest Lipiodol as a candidate for an internal surrogate for imaging guidance in SBRT. 11 Nakagawa et al. also demonstrated that CBCT is feasible for Lipiodol-assisted SBRT for liver tumors.
However, Lipiodol includes a high-density material such as iodine affecting the dose distribution. Garnica-Garza calculated the absorbed physical dose distributions for contrast-enhanced radiotherapy by performing Monte Carlo (MC) calculations of contrast-enhanced prostate treatment 13 with a 360°arc beam that was collimated to conform to the target from each direction, using a 220 keV mono-energetic electron pencil beam. From that study, contrast-enhanced prostate radiotherapy was concluded to be clinically achievable. However, MV beams have not been considered, and the dose enhancement in a contrast medium has not been investigated so far. The purpose of this study was to estimate the dose enhancement in the proximity of Lipiodol and to evaluate the dose calculation accuracy by the Acuros XB (AXB) algorithm and anisotropic analytical algorithm (AAA) compared to the MC calculation using the BEAMnrc/ DOSXYZnrc code for a virtual phantom and a treatment plan for liver SBRT after TACE.
METHODS AND MATERIALS
A TrueBeam linear accelerator (Varian Medical Systems, Palo Alto, USA) provides both 6 MV and 10 MV flattening filter-free (FFF) beams. The radiotherapy treatment planning system (RTPS) used in this study was Eclipse version 11 (Varian Medical Systems, Palo Alto, USA). The dose calculation algorithms used in the TPS were the AXB algorithm and the AAA. The AAA scales primary photons and photon scattering kernel in lateral directions according to the local electron density and uses the pencil beam convolution/ superposition technique. The AXB algorithm numerically solves the linear Boltzmann transport equation (LBTE) that describes the macroscopic behavior of radiation particles as they travel through and interact with the matter. The AXB method was performed in the dose-to-medium mode. The AAA was performed in the dose-to-water mode because the CT value was converted to the electron density. In the AXB method, the physical density and the corresponding material were automatically assigned to heterogeneous materials. The material composition of a given voxel in a 3D CT image was assigned automatically from the CT value based on our own CT calibration curve determined from the Gammex 467 Tissue Characterization Phantom (Gammex, Inc., Middleton, WI) and the material data in the AXB algorithm. In the AXB algorithm, the materials were assigned automatically to one of the following human body materials "Air," "Lung," "Adipose Tissue," "Muscle Skeletal," "Cartilage," and "Bone." According to the range of the CT values, there are overlapping physical density regions weighted linearly between two adjacent materials. The density ranges of "Air," "Lung," "Adipose Tissue," "Muscle Skeletal," "Cartilage," and "Bone" are 0.00-0.02, 0.01-0.62, 0.55-1.00, 0.97-1.09, 1.06-1.60, and 1.10-3.00 g/cm 3 respectively. For the MC calculation, the accelerator head components were proprietary and not available to the public for direct simulations. However, Varian Medical Systems provided IAEA-compliant phase-space files, and these were utilized for simulations using the GEANT4 MC code, located just above the secondary X/Y collimator. 14 The phase space was scored onto the surface of a cylinder located above the secondary collimator. Therefore, phase-space files below the secondary collimator were modeled with BEAMnrc. Dose calculation was performed with DOSXYZnrc. DOSXYZnrc source 20 in combination with synchronized beam-modifying components as shared library enabled single-run simulations of plans containing multiple fields or field segments. The plan parameters were exported from the TPS and converted into the input file format for the MC code package. Phase-space data scored at source-to-surface distance (SSD) of 70 cm were used as an input source for the inhomogeneous virtual phantom and a clinical CT image. The photon and electron cut-off energies were 0.01 and 0.7 MeV respectively. The dose calculation grid size was 2 9 2 9 2 cm 3 , which was the same as that in the AXB algorithm and AAA.
2.A. Validation of Monte Carlo calculation
The MC calculation was validated by comparing its results with the dosimetric measurement, which used radiochromic films (Gafchromic film, RTQA2, Ashland, USA). Lipiodol (3 9 3 9 3 cm 3 ) was inserted at a depth of 8.5 cm in a water-equivalent phantom (30 9 30 9 30 cm 3 ) (Fig. 1 ). The percent depth dose (PDD) and the off-axis ratio (OAR) were measured with the films sandwiched tightly in the phantom. To obtain the dose calibration curve, a small area of Gafchromic films (2 9 2 cm 2 ) was irradiated at a depth of 10 cm and SSD of 90 cm, with a field area 10 9 10 cm 2 . The calibration dose was delivered in steps of 25 cGy and 50 cGy in the ranges of 0-100 cGy and 100-400 cGy respectively. The calibration curve was used to convert the film optical density to the absolute dose. The PDD was calculated by the use of the measurement for a film area of 5 9 5 cm 2 at depths of 3.5, 6, 8.1, 8.5, 11.5, 11.9, and 13.5 cm in the phantom. The OAR at a depth of 10 cm was calculated by the use of the measurement of the horizontal profile of the irradiated films. Two hundred monitor units (MUs) with 10 MV FFF beam were delivered in each irradiation. Each measurement was repeated three times and, the standard deviation was confirmed within 2.3%. The measured and MC PDD curves were normalized by the calculated dose at a depth of 2.1 cm that is dmax of 10 9 FFF. The number of photon histories in BEAMnrc and DOSXYZnrc was 2.0 9 10 8 and 2.0 9 10 9 respectively. The statistical error of the calculation was within 1.0%.
2.B. Virtual phantom calculations
The dose difference in the Lipiodol between the doses in the phantoms with and without Lipiodol and the accuracy of the dose calculation algorithms in TPS were evaluated using a simple virtual phantom. A virtual water phantom (30 9 30 9 30 cm 3 ) was generated, in which Lipiodol (3 9 3 9 3 cm 3 ) was deposited at a depth of 8.5 cm, which was the same as that shown in Fig. 1 . The Lipiodol volume was set by considering realistic tumor sizes. The electron density of Lipiodol was overridden and was set to 1.28 g/cm 3 .
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Using the MC simulation, the PDD and OAR curves of the virtual water phantom with Lipiodol were calculated and compared with those of the phantom without Lipiodol. Moreover, the performances of the AXB algorithm and AAA were evaluated by comparing with the MC calculation.
2.C. Liver SBRT patient treatment plan calculations
The dose difference with and without Lipiodol and the accuracy of the dose calculation algorithms in TPS were validated using a clinical CT image. CT imaging of a patient with Lipiodol was performed during expiratory breath holding on a CT scanner (Lightspeed RT16, GE Healthcare, Little Chalfont, UK). Breath holding was coordinated in the expiratory phase with Abches (APEX Medical, Tokyo, Japan), which allows patients to control their chest and abdominal respiratory motion. The slice thickness and slice interval were 1.25 mm. The CT image and structure data were exported to our in-house system and translated into the format of MC calculations. This system was operated in MATLAB (The MathWorks, Natick, MA) to read CT image sets and structure sets in the DICOM format and create binary data files containing the voxelized information in a format easily inputted into the MC calculation. Then the translated data file was read into an array containing an element for each voxel in the original CT and structure dataset. For a given simulation, the patient was represented as lying in a digitized box with the same geometry as the CT image. Each element of the digitized box preserves the Hounsfield's unit (HU), spatial location of the original CT voxel, and structure data. For a material assignment, two processes were executed. First, the CT value was assigned to the material using the same method as the AXB algorithm. Next, the material information of Lipiodol was assigned to the structure of Lipiodol, which was already contoured in the RTPS. The gross tumor volume (GTV) was defined as the tumor volume containing residual Lipiodol from TACE and exhibiting early enhancement in the arterial phase of dynamic CT. The margin of the clinical target volume (CTV) was typically 5 mm around the GTV. A planning target volume (PTV) margin of 5-8 mm, including the respiratory motion reproducibility and setup error, was typically added. Eight beams (four coplanar and four non-coplanar beams) were used, avoiding irradiation of critical organs at risk (e.g. intact liver, spinal cord, right kidney, and duodenum) as much as possible.
RESULTS

3.A. Validation of the MC calculation
The MC calculation was validated by comparing its results with dosimetric measurements using radiochromic films. Figure 2 shows the measured and calculated PDD curves along the central axis. The relative statistical error of the dose calculation using the MC simulation was within 1%. The absorbed dose increased immediately upstream of and in the Lipiodol region, and decreased elsewhere. Outside the buildup region, the difference between the measured and calculated PDD was smaller than 3%, and was attributed to the film position. Figure 5 shows the dose distributions calculated by AAA, AXB algorithm, and MC simulation in the axial plane for a clinical case of liver SBRT. The dose distributions were normalized by the dose at the isocenter. In Fig. 5 , the red washed region indicates dose greater than 90%. This region volume is larger for the AAA than that for the AXB method and is the largest for the MC calculation. V 100% defined as the largest volume of a specified volume of interest, which receives more than or equal to 100% of the prescribed dose, was 27.1 cc for the AAA, 22.1 cc for the AXB algorithm, and 44.9 cc for the MC calculation. V 90% defined as the largest volume of a specified volume of interest, which receives 90% of the prescribed dose or more, was 32.2 cc for the AAA, 26.4 cc for the AXB algorithm, and 53.8 cc for the MC calculation. Figure 6 (a) shows the lateral dose profile in the isocenter plane, calculated using MC simulations, for the patient's plans with and without Lipiodol. The maximum difference between the doses with and without Lipiodol was 6.0%. As shown in Fig. 6(b) , the AAA and AXB methods underestimated the dose in the Lipiodol region by 10.2% and 12.5% at maximum compared with the MC calculation, and by 6.6% and 8.0% on average respectively.
3.B. Virtual phantom calculation
3.C. Liver SBRT patient treatment plan calculations
DISCUSSION
A previous study investigated the radiation dose around inhomogeneous human body irradiated by a photon beam. 15 That study reported dose escalation in a small area where the distance between a gold marker and the lung tumor was ≤5 mm, concluding that such dose escalation is clinically negligible in multi-beam treatments. In this study, the dose distributions in the regions inside and neighboring Lipiodol inserted in the tumor were evaluated using RTPS algorithms and MC calculation, and we reported the large dose enhancement in the Lipiodol region.
MC calculation was performed to evaluate the absorbed dose in and around the Lipiodol region. The MC calculation was assumed to calculate correct doses in water as well as in Lipiodol if the assigned material and the physical densities are corrected, even though the dose in Lipiodol cannot be measured. The measurements and the MC calculation agreed within 3%, as shown in Fig. 2 . The largest difference was 2.7% at a depth of 11.0 cm in the buildup region. This region was a boundary region, and the difference was mainly caused by the volume effect due to the grid size (2 mm) of the MC calculation.
As shown in Fig. 3(a) , the absorbed dose increased at depth A owing to backscattering of secondary electrons. At depth B, the absorbed dose increased owing to the mass energy absorption coefficient and mass collision stopping power ratio. A build-down effect was observed at depth C, reflecting the effect of electron disequilibrium in the boundary region behind the high-density region. However, in the clinical case, the dose enhancement around Lipiodol was not reduced, because the doses immediately upstream and downstream were offset owing to radiation beams from multiple directions, as shown in Fig. 6(a) .
On the other hand, as seen in Figs. 3(b) , 4(b) and 6(b), compared with the MC calculations, the AAA underestimated the doses at depths A and B and overestimated the dose at depth C. In the AAA, the material in the Lipiodol region was assigned to water, and the density of water based on the table of the CT values to ED, not accounting for the chemical properties of tissue or physical density; hence, the computed dose was defined as the dose to water, and was rescaled according to the specific electron density. There were additional discrepancies between the AXB and MC calculations, arising from the specification of the AXB method in which the Lipiodol region was automatically considered as a mixture of bone and cartilage. Although the main component of Lipiodol was iodine, one of the most significant drawbacks of the AXB algorithm is the absence of iodine from the material assignment list. In addition, bone and iodine have different mass-energy absorption coefficients and mass-collision stopping power ratios, but they are given similar CT values. Thus, although automatic assignment of material is difficult, the difference between the AXB and MC calculations is expected to be smaller if manual assignment of iodine becomes possible in the AXB method.
In our discussion so far, we have not evaluated the dose in the tumor region but only the dose in the Lipiodol region of a certain density. Lipiodol did not invade tumor cells; rather, the tumor cells were surrounded by Lipiodol molecules. In this study, we did not consider the arrangement of Lipiodol molecules and tumor cells on the CT image. In the previous study, it was found that the photon source energy and the size of Au nanoparticles (AuNPs) in a high-density material like iodine, influence the spatial distribution of the energy deposited around AuNPs. 16 It was suggested that electrons lose their energy over a larger distance and can cross-fire between cells, they but can still cause significant DNA damage. The effect depended mostly on the energy spectrum of incident photons, with more energetic photons yielding higher-energy and longer range photoelectrons. Therefore, the energy of secondary electrons is likely to be high enough to cross-fire tumor cells in the proximity of Lipiodol molecules, and the dose to these tumor cells can be assumed to be almost equal to the dose delivered to Lipiodol. Moreover, it was difficult to estimate the concentration of Lipiodol based on the clinical CT images. The patterns of the uptake of Lipiodol around the tumor would differ clinically from case to case. In the current study, the GTV region is homogeneous for the dose calculation, even though it looks inhomogeneous on the patient's CT image section, where the whole GTV is overridden to Lipiodol. The future work of this study is focused on making the distribution of the Lipiodol uptake to the CT value table. Moreover, we would like to consider the microscopic spatial relationship between Lipiodol and cells.
CONCLUSION
This study evaluated the impact of Lipiodol on the dose distribution by comparing the dosimetric performance of the AXB, AAA, and MC calculations, using a virtual heterogeneous phantom and a treatment plan for liver SBRT after TACE. The TPS algorithms could not calculate the dose in Lipiodol accurately. The MC calculation demonstrated a larger increase in the dose in the Lipiodol region. This dose enhancement could be potentially clinically significant.
